The company's presence highlights Dublin’s growing reputation as a destination for innovation, connectivity and business ...

Labcorp Holdings Inc (LH) reports a robust 9% revenue increase and a 19% rise in adjusted EPS, while navigating challenges in ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday, as a prolonged funding crunch continues to weigh on its early-stage drug development clients.

Q3 2025 Earnings Call Transcript October 28, 2025 Labcorp Holdings Inc. beats earnings expectations. Reported EPS is $4.18, ...

Laboratory Corporation Of America ( ($LH) ) has released its Q3 earnings. Here is a breakdown of the information Laboratory Corporation Of America ...

Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong ...

As a leading independent diagnostic laboratory, Labcorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, Medicare ...

Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell 3.8% in the morning session after the company's ...

BLS revenue reached $799 million, up 8.3%, and adjusted operating income grew to $132 million. The quarter ended with an $8.6 billion backlog, and the BLS book-to-bill was 0.89 for the quarter and ...

Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...